Hepatic tumor necrosis factor signaling and nuclear factor-κB: Effects on liver homeostasis and beyond

Endocrine Reviews

Volumn 28, Issue 4, 2007, Pages 365-386

  Wullaert, Andy ^a,b   Van Loo, Geert ^a   Heyninck, Karen ^a   Beyaert, Rudi ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 2; FLICE INHIBITORY PROTEIN; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; CANCER CELL; CELL PROLIFERATION; CELL PROTECTION; EMBRYOTOXICITY; ENDOCRINE FUNCTION; ENZYME ACTIVATION; FATTY LIVER; GENE EXPRESSION REGULATION; HEMOCHROMATOSIS; HEPATITIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIVER CARCINOGENESIS; LIVER CELL; LIVER INJURY; LIVER METABOLISM; LIVER MITOCHONDRION; LIVER NECROSIS; LIVER REGENERATION; LIVER TOXICITY; METABOLIC SYNDROME X; MITOCHONDRIAL PERMEABILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HOMEOSTASIS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; LIVER REGENERATION; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250840799     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2006-0031     Document Type: Review

References (193)

1. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ 2002 Mechanisms of hepatotoxicity. Toxicol Sci 65:166-176
2. Bradham CA, Plumpe J, Manns MP, Brenner DA, Trautwein C 1998 Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol 275:G387-G392
3. Karin M, Greten FR 2005 NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759
4. Kallinowski B, Haseroth K, Marinos G, Hanck C, Stremmel W, Theilmann L, Singer MV, Rossol S 1998 Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 111:269-277
5. Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, Urdea MS, Kolberg JA, Lau JY 1997 Activation of tumor necrosis factor-α system in chronic hepatitis C virus infection. Dig Dis Sci 42:2487-2494
6. Sheron N, Lau J, Daniels H, Goka J, Eddleston A, Alexander GJ, Williams R 1991 Increased production of tumour necrosis factor α in chronic hepatitis B virus infection. J Hepatol 12:241-245
7. Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M, Wakita T, Ishikawa T, Mizokami M 1990 Immunohistochemical studies of intrahepatic tumour necrosis factor α in chronic liver disease. J Clin Pathol 43:298-302
8. Spengler U, Zachoval R, Gallati H, Jung MC, Hoffmann R, Riethmuller G, Pape G 1996 Serum levels and in situ expression of TNF-α and TNF-α binding proteins in inflammatory liver diseases. Cytokine 8:864-872
9. Gonzalez-Amaro R, Garcia-Monzon C, Garcia-Buey L, Moreno-Otero R, Alonso JL, Yague E, Pivel JP, Lopez-Cabrera M, Fernandez-Ruiz E, Sanchez-Madrid F 1994 Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J Exp Med 179:841-848
10. Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL, Williams R 1988 Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 2:72-74
11. Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS 1990 Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112:917-920
12. McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I 2004 Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 287:G497-G502
13. Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG 1997 Antibodies to tumor necrosis factor α attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530-1537
14. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG 1999 Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice. Gastroenterology 117:942-952
15. Rudiger HA, Clavien PA 2002 Tumor necrosis factor α, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 122:202-210
16. Feingold KR, Soued M, Grunfeld C 1988 Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem Biophys Res Commun 153:576-582
17. Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM 1992 Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am J Physiol 263:G579-G585
18. Yamada Y, Kirillova I, Peschon JJ, Fausto N 1997 Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 94:1441-1446
19. Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N 1998 Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology 28:959-970
20. Shoelson SE, Lee J, Goldfine AB 2006 Inflammation and insulin resistance. J Clin Invest 116:1793-1801
21. Fargion S, Valenti L, Dongiovanni P, Scaccabarozzi A, Fracanzani AL, Taioli E, Mattioli M, Sampietro M, Fiorelli G 2001 Tumor necrosis factor α promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood 97:3707-3712
22. Micheau O, Tschopp J 2003 Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190
23. Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J, Heinrich M, Merkel O, Ehrenschwender M, Adam D, Mentlein R, Kabelitz D, Schutze S 2004 Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21:415-428
24. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ 1995 Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348-351
25. Kim EY, Teh HS 2001 TNF type 2 receptor (p75) lowers the threshold of T cell activation. J Immunol 167:6812-6820
26. Depuydt B, van Loo G, Vandenabeele P, Declercq W 2005 Induction of apoptosis by TNF receptor 2 in a T-cell hybridoma is FADD dependent and blocked by caspase-8 inhibitors. J Cell Sci 118:497-504
27. Tartaglia LA, Pennica D, Goeddel DV 1993 Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18542-18548
28. Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC, Wu Lee YH, Durkop H, Engelmann H, Scheurich P, Wajant H, Strasser A 1999 Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18:3034-3043
29. Kusters S, Tiegs G, Alexopoulou L, Pasparakis M, Douni E, Kunstle G, Bluethmann H, Wendel A, Pfizenmaier K, Kollias G, Grell M 1997 In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol 27:2870-2875
30. Douni E, Kollias G 1998 A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin α, or the p55TNF-R. J Exp Med 188:1343-1352
31. Hayden MS, Ghosh S 2004 Signaling to NF-κB. Genes Dev 18:2195-2224
32. Sun L, Chen ZJ 2004 The novel functions of ubiquitination in signaling. Curr Opin Cell Biol 16:119-126
33. Wullaert A, Heyninck K, Janssens S, Beyaert R 2006 Ubiquitin: tool and target for intracellular NF-κB inhibitors. Trends Immunol 27:533-540
34. Chen G, Goeddel DV 2002 TNF-R1 signaling: a beautiful pathway. Science 296:1634-1635
35. Chen ZJ 2005 Ubiquitin signalling in the NF-κB pathway. Nat Cell Biol 7:758-765
36. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O, Akira S 2005 Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6:1087-1095
37. Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, Lee KY, Bussey C, Steckel M, Tanaka N, Yamada G, Akira S, Matsumoto K, Ghosh S 2005 TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 19:2668-2681
38. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ 2001 TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346-351
39. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME 1998 Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675-1687
40. Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ 1998 The mitochondrial permeability transition is required for tumor necrosis factor α-mediated apoptosis and cytochrome c release. Mol Cell Biol 18:6353-6364
41. Osawa Y, Banno Y, Nagaki M, Nozawa Y, Moriwaki H, Nakashima S 2001 Caspase activation during hepatocyte apoptosis induced by tumor necrosis factor-α in galactosamine-sensitized mice. Liver 21:309-319
42. Imao M, Nagaki M, Imose M, Moriwaki H 2006 Differential caspase-9-dependent signaling pathway between tumor necrosis factor receptor- and Fas-mediated hepatocyte apoptosis in mice. Liver Int 26:137-146
43. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ 2001 Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730
44. Zhao Y, Li S, Childs EE, Kuharsky DK, Yin XM 2001 Activation of pro-death Bcl-2 family proteins and mitochondria apoptosis pathway in tumor necrosis factor-α-induced liver injury. J Biol Chem 276:27432-27440
45. Zhao Y, Ding WX, Qian T, Watkins S, Lemasters JJ, Yin XM 2003 Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement. Gastroenterology 125:854-867
46. Soriano ME, Nicolosi L, Bernardi P 2004 Desensitization of the permeability transition pore by cyclosporin a prevents activation of the mitochondrial apoptotic pathway and liver damage by tumor necrosis factor-α. J Biol Chem 279:36803-36808
47. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH, Gores GJ 2000 Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106:1127-1137
48. Guicciardi ME, Miyoshi H, Bronk SF, Gores GJ 2001 Cathepsin B knockout mice are resistant to tumor necrosis factor-α-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am J Pathol 159:2045-2054
49. Guicciardi ME, Bronk SF, Werneburg NW, Yin XM, Gores GJ 2005 Bid is upstream of lysosome-mediated caspase 2 activation in tumor necrosis factor α-induced hepatocyte apoptosis. Gastroenterology 129:269-284
50. Ding WX, Ni HM, DiFrancesca D, Stolz DB, Yin XM 2004 Biddependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes. Hepatology 40:403-413
51. Okuyama H, Nakamura H, Shimahara Y, Araya S, Kawada N, Yamaoka Y, Yodoi J 2003 Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology 37:1015-1025
52. Wu J, Liu L, Yen RD, Catana A, Nantz MH, Zern MA 2004 Liposome-mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice. Hepatology 40:195-204
53. Garcia-Ruiz C, Colell A, Mari M, Morales A, Calvo M, Enrich C, Fernandez-Checa JC 2003 Defective TNF-α-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest 111:197-208
54. Malagarie-Cazenave S, Segui B, Leveque S, Garcia V, Carpentier S, Altie MF, Brouchet A, Gouaze V, Andrieu-Abadie N, Barreira Y, Benoist H, Levade T 2004 Role of FAN in tumor necrosis factor-α and lipopolysaccharide- induced interleukin-6 secretion and lethality in D-galactosamine-sensitized mice. J Biol Chem 279:18648-18655
55. Mari M, Colell A, Morales A, Paneda C, Varela-Nieto I, Garcia-Ruiz C, Fernandez-Checa JC 2004 Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis. J Clin Invest 113:895-904
56. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC 1997 Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem 272:11369-11377
57. Garcia-Ruiz C, Colell A, Paris R, Fernandez-Checa JC 2000 Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB J 14:847-858
58. Garcia-Ruiz C, Colell A, Morales A, Calvo M, Enrich C, Fernandez-Checa JC 2002 Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-α. J Biol Chem 277:36443-36448
59. Woo CH, Eom YW, Yoo MH, You HJ, Han HJ, Song WK, Yoo YJ, Chun JS, Kim JH 2000 Tumor necrosis factor-α generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem 275:32357-32362
60. O'Donnell VB, Spycher S, Azzi A 1995 Involvement of oxidants and oxidant-generating enzyme(s) in tumour-necrosis-factor-α-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain. Biochem J 310 (Pt 1):133-141
61. Foghsgaard L, Lademann U, Wissing D, Poulsen B, Jaattela M 2002 Cathepsin B mediates tumor necrosis factor-induced arachidonic acid release in tumor cells. J Biol Chem 277:39499-39506
62. Wissing D, Mouritzen H, Egeblad M, Poirier GG, Jaattela M 1997 Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci USA 94:5073-5077
63. Streetz KL, Wustefeld T, Klein C, Kallen KJ, Tronche F, Betz UA, Schutz G, Manns MP, Muller W, Trautwein C 2003 Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology 125:532-543
64. Camargo Jr CA, Madden JF, Gao W, Selvan RS, Clavien PA 1997 Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26:1513-1520
65. Libert C, Brouckaert P, Fiers W 1994 Protection by α 1-acid glycoprotein against tumor necrosis factor-induced lethality. J Exp Med 180:1571-1575
66. Libert C, Van Molle W, Brouckaert P, Fiers W 1996 α1-Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 157:5126-5129
67. Van Molle W, Libert C, Fiers W, Brouckaert P 1997 α1-Acid glycoprotein and α 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J Immunol 159:3555-3564
68. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D 1995 Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170
69. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, Goeddel DV 1999 Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10:421-429
70. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, Karin M 1999 The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J Exp Med 189:1839-1845
71. Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, Potter J, Elia AJ, Mak TW 2000 Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice. Genes Dev 14:854-862
72. Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ, Obata Y 1999 Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA 96:2994-2999
73. Rosenfeld ME, Prichard L, Shiojiri N, Fausto N 2000 Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol 156:997-1007
74. Alcamo E, Mizgerd JP, Horwitz BH, Bronson R, Beg AA, Scott M, Doerschuk CM, Hynes RO, Baltimore D 2001 Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J Immunol 167:1592-1600
75. Bellas RE, FitzGerald MJ, Fausto N, Sonenshein GE 1997 Inhibition of NF-κB activity induces apoptosis in murine hepatocytes. Am J Pathol 151:891-896
76. Xu Y, Bialik S, Jones BE, Iimuro Y, Kitsis RN, Srinivasan A, Brenner DA, Czaja MJ 1998 NF-κB inactivation converts a hepatocyte cell line TNF-α response from proliferation to apoptosis. Am J Physiol 275:C1058-C1066
77. Nagaki M, Naiki T, Brenner DA, Osawa Y, Imose M, Hayashi H, Banno Y, Nakashima S, Moriwaki H 2000 Tumor necrosis factor α prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-κB. Hepatology 32:1272-1279
78. Chaisson ML, Brooling JT, Ladiges W, Tsai S, Fausto N 2002 Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 110:193-202
79. Luedde T, Assmus U, Wustefeld T, Meyer zu Vilsendorf A, Roskams T, Schmidt-Supprian M, Rajewsky K, Brenner DA, Manns MP, Pasparakis M, Trautwein C 2005 Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 115:849-859
80. Decker K, Keppler D 1974 Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 71:77-106
81. Nagaki M, Sugiyama A, Osawa Y, Naiki T, Nakashima S, Nozawa Y, Moriwaki H 1999 Lethal hepatic apoptosis mediated by tumor necrosis factor receptor, unlike Fas-mediated apoptosis, requires hepatocyte sensitization in mice. J Hepatol 31:997-1005
82. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H 1993 Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802
83. Leist M, Gantner F, Jilg S, Wendel A 1995 Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 154:1307-1316
84. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G 1995 Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21:190-198
85. Libert C, Van Bladel S, Brouckaert P, Shaw A, Fiers W 1991 Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor. J Immunol 146:2625-2632
86. Lavon I, Goldberg I, Amit S, Landsman L, Jung S, Tsuberi BZ, Barshack I, Kopolovic J, Galun E, Bujard H, Ben-Neriah Y 2000 High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation. Nat Med 6:573-577
87. Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R, Roskams T, Trautwein C, Pasparakis M 2007 Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11:119-132
88. Maeda S, Chang L, Li ZW, Luo JL, Leffert H, Karin M 2003 IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19:725-737
89. Ogushi I, Iimuro Y, Seki E, Son G, Hirano T, Hada T, Tsutsui H, Nakanishi K, Morishita R, Kaneda Y, Fujimoto J 2003 Nuclear factor κB decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model. Hepatology 38:335-344
90. Wheeler MD, Yamashina S, Froh M, Rusyn I, Thurman RG 2001 Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-κB activation and cytokine production. J Leukoc Biol 69:622-630
91. Uesugi T, Froh M, Arteel GE, Bradford BU, Gabele E, Wheeler MD, Thurman RG 2001 Delivery of IκB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats. Hepatology 34:1149-1157
92. Suetsugu H, Iimuro Y, Uehara T, Nishio T, Harada N, Yoshida M, Hatano E, Son G, Fujimoto J, Yamaoka Y 2005 Nuclear factor κB inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury. Gut 54:835-842
93. Fan C, Li Q, Zhang Y, Liu X, Luo M, Abbott D, Zhou W, Engelhardt JF 2004 IκBα and IκBβ possess injury context-specific functions that uniquely influence hepatic NF-κB induction and inflammation. J Clin Invest 113:746-755
94. Cheng JD, Ryseck RP, Attar RM, Dambach D, Bravo R 1998 Functional redundancy of the nuclear factor κB inhibitors IκBα and IκBβ. J Exp Med 188:1055-1062
95. Zwacka RM, Zhang Y, Zhou W, Halldorson J, Engelhardt JF 1998 Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor κB independently of IκB degradation. Hepatology 28:1022-1030
96. Michalopoulos GK, DeFrances MC 1997 Liver regeneration. Science 276:60-66
97. Cressman DE, Greenbaum LE, Haber BA, Taub R 1994 Rapid activation of post-hepatectomy factor/nuclear factor κB in hepatocytes, a primary response in the regenerating liver. J Biol Chem 269:30429-30435
98. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, Brenner DA 1998 NFκB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 101:802-811
99. Plumpe J, Malek NP, Bock CT, Rakemann T, Manns MP, Trautwein C 2000 NF-κB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol Gastrointest Liver Physiol 278:G173-G183
100. Kirillova I, Chaisson M, Fausto N 1999 Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor κB activation. Cell Growth Differ 10:819-828
101. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R 1996 Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379-1383
102. Yang L, Magness ST, Bataller R, Rippe RA, Brenner DA 2005 NF-κB activation in Kupffer cells after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 289:G530-G538
103. Hellerbrand C, Jobin C, Iimuro Y, Licato L, Sartor RB, Brenner DA 1998 Inhibition of NFκB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super-repressor. Hepatology 27:1285-1295
104. Hanahan D, Weinberg RA 2000 The hallmarks of cancer. Cell 100:57-70
105. Bond M, Fabunmi RP, Baker AH, Newby AC 1998 Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-κB. FEBS Lett 435:29-34
106. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM 1992 Interleukin-8 as a macrophagederived mediator of angiogenesis. Science 258:1798-1801
107. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y 2004 NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431:461-466
108. Maeda S, Kamata H, Luo JL, Leffert H, Karin M 2005 IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121:977-990
109. Sakurai T, Maeda S, Chang L, Karin M 2006 Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci USA 103:10544-10551
110. Lieber CS 2004 Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34:9-19
111. Farrell GC, Larter CZ 2006 Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99-S112
112. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91
113. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A 1993 Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058
114. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE 2001 Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 293:1673-1677
115. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI 2001 Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108:437-446
116. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI 2002 Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109:1321-1326
117. Rohl M, Pasparakis M, Baudler S, Baumgartl J, Gautam D, Huth M, De Lorenzi R, Krone W, Rajewsky K, Bruning JC 2004 Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance. J Clin Invest 113:474-481
118. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 11:183-190
119. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M 2005 IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 11:191-198
120. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC 1997 Excess weight risk factor for alcoholic liver disease. Hepatology 25:108-111
121. Robin MA, Demeilliers C, Sutton A, Paradis V, Maisonneuve C, Dubois S, Poirel O, Letteron P, Pessayre D, Fromenty B 2005 Alcohol increases tumor necrosis factor α and decreases nuclear factor-κB to activate hepatic apoptosis in genetically obese mice. Hepatology 42:1280-1290
122. DeAngelis RA, Markiewski MM, Taub R, Lambris JD 2005 A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-κB inhibitor, IκBα. Hepatology 42:1148-1157
123. Guebre-Xabier M, Yang S, Lin HZ, Schwenk R, Krzych U, Diehl AM 2000 Altered hepatic lymphocyte subpopulations in obesityrelated murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology 31:633-640
124. Li Z, Soloski MJ, Diehl AM 2005 Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42:880-885
125. Li Z, Lin H, Yang S, Diehl AM 2002 Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. Gastroenterology 123:1304-1310
126. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM 1997 Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 94:2557-2562
127. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold KR, Grunfeld C, Fantuzzi G 2000 Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor α and IL-18. Proc Natl Acad Sci USA 97:2367-2372
128. Hentze MW, Muckenthaler MU, Andrews NC 2004 Balancing acts: molecular control of mammalian iron metabolism. Cell 117:285-297
129. Pietrangelo A 2006 Hereditary hemochromatosis. Biochim Biophys Acta 1763:700-710
130. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo Jr R, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK 1996 A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408
131. Ahmad KA, Ahmann JR, Migas MC, Waheed A, Britton RS, Bacon BR, Sly WS, Fleming RE 2002 Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis 29:361-366
132. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K 2000 LEAP-1, a novel highly disulfidebonded human peptide, exhibits antimicrobial activity. FEBS Lett 480:147-150
133. Park K, Verchere CB 2001 Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation. J Biol Chem 276:16611-16616
134. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O 2001 A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811-7819
135. Muckenthaler M, Richter A, Gunkel N, Riedel D, Polycarpou-Schwarz M, Hentze S, Falkenhahn M, Stremmel W, Ansorge W, Hentze MW 2003 Relationships and distinctions in iron-regulatory networks responding to interrelated signals. Blood 101:3690-3698
136. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S 2002 The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110:1037-1044
137. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S 2001 Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98:8780-8785
138. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S 2002 Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99:4596-4601
139. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T 2004 IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271-1276
140. Lee P, Peng H, Gelbart T, Beutler E 2004 The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and β 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci USA 101:9263-9265
141. Montosi G, Corradini E, Garuti C, Barelli S, Recalcati S, Cairo G, Valli L, Pignatti E, Vecchi C, Ferrara F, Pietrangelo A 2005 Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. Hepatology 41:545-552
142. Gordeuk VR, Ballou S, Lozanski G, Brittenham GM 1992 Decreased concentrations of tumor necrosis factor-α in supernatants of monocytes from homozygotes for hereditary hemochromatosis. Blood 79:1855-1860
143. Hirayama M, Kohgo Y, Kondo H, Shintani N, Fujikawa K, Sasaki K, Kato J, Niitsu Y 1993 Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron. Hepatology 18:874-880
144. Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC 1997 Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 90:4979-4986
145. Cornejo P, Varela P, Videla LA, Fernandez V 2005 Chronic iron overload enhances inducible nitric oxide synthase expression in rat liver. Nitric Oxide 13:54-61
146. Xiong S, She H, Sung CK, Tsukamoto H 2003 Iron-dependent activation of NF-κB in Kupffer cells: a priming mechanism for alcoholic liver disease. Alcohol 30:107-113
147. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J 2001 NF-κB signals induce the expression of c-FLIP. Mol Cell Biol 21:5299-5305
148. Chen C, Edelstein LC, Gelinas C 2000 The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20:2687-2695
149. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C 1999 The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev 13:382-387
150. Opipari Jr AW, Hu HM, Yabkowitz R, Dixit VM 1992 The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 267:12424-12427
151. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J 1998 Nuclear factor (NF)-κB-regulated X-chromosomelinked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J Exp Med 188:211-216
152. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS 1998 NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683
153. Werner AB, de Vries E, Tait SW, Bontjer I, Borst J 2002 Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit its collaboration with pro-apoptotic Bak or Bax. J Biol Chem 277:22781-22788
154. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC 1997 The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16:6914-6925
155. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC 1998 IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17:2215-2223
156. de la Coste A, Fabre M, McDonell N, Porteu A, Gilgenkrantz H, Perret C, Kahn A, Mignon A 1999 Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. Am J Physiol 277:G702-G708
157. Duriez PJ, Wong F, Dorovini-Zis K, Shahidi R, Karsan A 2000 A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor. J Biol Chem 275:18099-18107
158. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW 1997 Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc Natl Acad Sci USA 94:10057-10062
159. Zapata JM, Krajewska M, Krajewski S, Kitada S, Welsh K, Monks A, McCloskey N, Gordon J, Kipps TJ, Gascoyne RD, Shabaik A, Reed JC 2000 TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies. J Immunol 165:5084-5096
160. Javelaud D, Besancon F 2001 NF-κB activation results in rapid inactivation of JNK in TNF α-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-κB. Oncogene 20:4365-4372
161. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R, Franzoso G 2001 Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling. Nature 414:308-313
162. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A 2001 Inhibition of JNK activation through NF-κB target genes. Nature 414:313-317
163. Tang F, Tang G, Xiang J, Dai Q, Rosner MR, Lin A 2002 The absence of NF-κB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor α-induced apoptosis. Mol Cell Biol 22:8571-8579
164. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M 2006 The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIP(L) turnover. Cell 124:601-613
165. Wang Y, Singh R, Lefkowitch JH, Rigoli RM, Czaja MJ 2006 Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J Biol Chem 281:15258-15267
166. Liu H, Lo CR, Czaja MJ 2002 NF-κB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 35:772-778
167. Schwabe RF, Uchinami H, Qian T, Bennett BL, Lemasters JJ, Brenner DA 2004 Differential requirement for c-Jun NH2-terminal kinase in TNFα- and Fas-mediated apoptosis in hepatocytes. FASEB J 18:720-722
168. Marderstein EL, Bucher B, Guo Z, Feng X, Reid K, Geller DA 2003 Protection of rat hepatocytes from apoptosis by inhibition of c-Jun N-terminal kinase. Surgery 134:280-284
169. Bradham CA, Stachlewitz RF, Gao W, Qian T, Jayadev S, Jenkins G, Hannun Y, Lemasters JJ, Thurman RG, Brenner DA 1997 Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 25:1128-1135
170. Uehara T, Xi Peng X, Bennett B, Satoh Y, Friedman G, Currin R, Brenner DA, Lemasters J 2004 c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation 78:324-332
171. Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, Westwick JK, Brenner DA 2005 JNK mediates hepatic ischemia reperfusion injury. J Hepatol 42:850-859
172. Trautwein C, Rakemann T, Brenner DA, Streetz K, Licato L, Manns MP, Tiegs G 1998 Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 114:1035-1045
173. Streetz K, Fregien B, Plumpe J, Korber K, Kubicka S, Sass G, Bischoff SC, Manns MP, Tiegs G, Trautwein C 2001 Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failure. J Immunol 167:514-523
174. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A 2000 Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289:2350-2354
175. Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, Mahiou J, Czismadia E, Abu-Jawdeh G, Ferran C 2002 A20 protects mice from D-galactosamine/ lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35:535-543
176. Wullaert A, Wielockx B, Van Huffel S, Bogaert V, De Geest B, Papeleu P, Schotte P, El Bakkouri K, Heyninck K, Libert C, Beyaert R 2005 Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality. Hepatology 42:381-389
177. Wullaert A, Verstrepen L, Van Huffel S, Adib-Conquy M, Cornelis S, Kreike M, Haegman M, El Bakkouri K, Sanders M, Verhelst K, Carpentier I, Cavaillon JM, Heyninck K, Beyaert R 2007 LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-κB activation. J Biol Chem 282:81-90
178. Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y, Piao JH, Yagita H, Okumura K, Doi T, Nakano H 2003 NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 22:3898-3909
179. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M 2005 Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120:649-661
180. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H 1998 Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17:2596-2606
181. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H 2001 ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2:222-228
182. Gilot D, Loyer P, Corlu A, Glaise D, Lagadic-Gossmann D, Atfi A, Morel F, Ichijo H, Guguen-Guillouzo C 2002 Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation. J Biol Chem 277:49220-49229
183. Sass G, Shembade ND, Tiegs G 2005 Tumour necrosis factor α (TNF)-TNF receptor 1-inducible cytoprotective proteins in the mouse liver: relevance of suppressors of cytokine signalling. Biochem J 385:537-544
184. He Y, Zhang W, Zhang R, Zhang H, Min W 2006 Socs1 inhibits TNF-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation. J Biol Chem 281:5559-5566
185. Tsutsui T, Koide H, Fukahori H, Isoda K, Higashiyama S, Maeda I, Tashiro F, Yamato E, Miyazaki J, Yodoi J, Kawase M, Yagi K 2003 Adenoviral transfection of hepatocytes with the thioredoxin gene confers protection against apoptosis and necrosis. Biochem Biophys Res Commun 307:765-770
186. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M 2003 The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 9:575-581
187. Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P 1998 Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187:1477-1485
188. Cauwels A, Janssen B, Waeytens A, Cuvelier C, Brouckaert P 2003 Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat Immunol 4:387-393
189. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS 2002 A central role for JNK in obesity and insulin resistance. Nature 420:333-336
190. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS 2006 Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci USA 103:10741-10746
191. Solinas G, Naugler W, Galimi F, Lee MS, Karin M 2006 Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci USA 103:16454-16459
192. Longo CR, Patel VI, Shrikhande GV, Scali ST, Csizmadia E, Daniel S, Sun DW, Grey ST, Arvelo MB, Ferran C 2005 A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism. Hepatology 42:156-164
193. Lademann U, Kallunki T, Jaattela M 2001 A20 zinc finger protein inhibits TNF-induced apoptosis and stress response early in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins. Cell Death Differ 8:265-272